Remove 2020 Remove Clinical Trials Remove Conditions
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. A 2022 meta-analysis of 23 studies published in Clinical Pharmacology & Therapeutics found that therapeutic effects plateau at relatively low doses for most conditions.

article thumbnail

The Science Behind Charlotte’s Web: How CBD Oil Works for Seizure Disorders

LifeCannMD

Florida recognizes epilepsy as a qualifying condition, so you don’t need to prove that everything else failed first. A terminal condition diagnosed by a physician other than the qualified physician issuing the physician certification. Epilepsy is actually a qualifying condition for Medical Marijuana in the State of Florida.

CBD 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

article thumbnail

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

PTSD is a mental health disability that affects approximately 5% of US adults in a given year, with an estimated 13 million cases reported nationally in 2020. The regulatory board also required Lykos to conduct an additional late-stage clinical trial to further test the safety and efficacy of MDMA therapy.

article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5 ” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy.

article thumbnail

Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent

NORML

They reported “circumstantial evidence” suggesting that CBD may possess antiviral acticity in a limited number of conditions, specifically in the treatment of hepatitis C and Karposi sarcoma. However, this data was based solely on preclinical findings.

CBD 300